Frontiers in Oncology | Hematologic Malignancies

Case Report

Published on 29 Jan 2024

Case report: Successful treatment of a patient with relapsed/refractory primary central nervous system lymphoma with thiotepa-based induction, autologous stem cell transplantation and maintenance

in Hematologic Malignancies

Luyao Wang
Yili Fan
Boxiao Chen
Jiawei Zhang
Luyu Yang
Xi Qiu
Huawei Jiang
Jinfan Li
Xibin Xiao
Liansheng Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1333761

1,972 views
1 citation

Review

Published on 29 Jan 2024

Targeting the DNA damage response in hematological malignancies

in Hematologic Malignancies

Sanjay De Mel
Ainsley Ryan Lee
Joelle Hwee Inn Tan
Rachel Zi Yi Tan
Li Mei Poon
Esther Chan
Joanne Lee
Yen Lin Chee
Satish R. Lakshminarasappa
Patrick William Jaynes

Frontiers in Oncology

doi 10.3389/fonc.2024.1307839

2,700 views
2 citations

Systematic Review

Published on 25 Jan 2024

Daratumumab-based immunotherapy vs. lenalidomide, bortezomib and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: a systemic review

in Hematologic Malignancies

Wenjiao Tang
Li Zhang
Yuhuan Zheng
Ling Pan
Ting Niu

Frontiers in Oncology

doi 10.3389/fonc.2024.1286029

4,016 views
2 citations

Case Report

Published on 25 Jan 2024

CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature

in Hematologic Malignancies

Alessandra Sperotto
Maria Teresa Lupo Stanghellini
Jacopo Peccatori
Roberta De Marchi
Simona Piemontese
Giulia Ciotti
Marco Basso
Elisabetta Pierdomenico
Paolo Fiore
Fabio Ciceri

Frontiers in Oncology

doi 10.3389/fonc.2023.1291457

2,009 views

Review

Published on 25 Jan 2024

Advances in the treatment of relapsed/refractory marginal zone lymphoma

in Hematologic Malignancies

Haotian Wang
Xin Wan
Ying Zhang
Jing Guo
Ou Bai

Frontiers in Oncology

doi 10.3389/fonc.2024.1327309

7,928 views
1 citation

Case Report

Published on 23 Jan 2024

Sequential autologous CAR-T and allogeneic CAR-T therapy successfully treats central nervous system involvement relapsed/refractory ALL: a case report and literature review

in Hematologic Malignancies

Yifan Liu
Yanfen Li
Zhangyu Yu
Rongrong Wang
Yu Jing

Frontiers in Oncology

doi 10.3389/fonc.2024.1341682

2,610 views
1 citation

Review

Published on 23 Jan 2024

Immune checkpoint blockade in hematological malignancies: current state and future potential

in Hematologic Malignancies

Prateek Pophali
Juan Carlos Varela
Jacalyn Rosenblatt

Frontiers in Oncology

doi 10.3389/fonc.2024.1323914

5,029 views
7 citations

Original Research

Published on 23 Jan 2024

Stromal area differences with epithelial-mesenchymal transition gene changes in conjunctival and orbital mucosa-associated lymphoid tissue lymphoma

in Hematologic Malignancies

Mizuki Tagami
Hiroaki Kasashima
Anna Kakehashi
Atsuko Yoshikawa
Mizuho Nishio
Norihiko Misawa
Atsushi Sakai
Hideki Wanibuchi
Masakazu Yashiro
Atsushi Azumi

Frontiers in Oncology

doi 10.3389/fonc.2024.1277749

1,440 views
2 citations

Original Research

Published on 19 Jan 2024

Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers

in Hematologic Malignancies

Yu Chang
Shiyong Li
Zhiming Li
Xinhua Wang
Fangyuan Chang
Shuaipeng Geng
Dandan Zhu
Guolin Zhong
Wei Wu
Yinyin Chang

Frontiers in Oncology

doi 10.3389/fonc.2024.1341997

3,119 views
3 citations

Case Report

Published on 19 Jan 2024

Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report

in Hematologic Malignancies

Roshan Asrani
Turgot Bora Cengiz
Bruce E. Petersen
Theodora Anagnostou
Joshua D. Brody

Frontiers in Oncology

doi 10.3389/fonc.2023.1254256

1,797 views

Original Research

Published on 17 Jan 2024

On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost

in Hematologic Malignancies

Li-qiong Hou
Jun-Ru Liu
Jing-Li Gu
Mei-Lan Chen
Li-Fen Kuang
Bei-Hui Huang
Wai-yi Zou
Juan Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1306367

1,717 views

Original Research

Published on 15 Jan 2024

Prognostic significance of Wilms’ tumor gene 1 expression in children with B-cell precursor acute lymphoblastic leukemia

in Hematologic Malignancies

Yu-juan Xue
Yu Wang
Le-ping Zhang
Ai-dong Lu
Yue-ping Jia
Ying-xi Zuo
Hui-min Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1297870

1,540 views

Review

Published on 12 Jan 2024

Co-occurrence of JAK2-V617 F mutation and BCR::ABL1 translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination

in Hematologic Malignancies

Magda Zanelli
Alessandra Bisagni
Francesca Sanguedolce
Giuseppe Broggi
Valentina Fragliasso
Maurizio Zizzo
Andrea Palicelli
Giovanni Martino
Camilla Cresta
Cecilia Caprera

Frontiers in Oncology

doi 10.3389/fonc.2023.1329298

4,515 views
4 citations

Original Research

Published on 11 Jan 2024

Identification and validation of a prognostic risk-scoring model for AML based on m7G-associated gene clustering

in Hematologic Malignancies

Chiyi Zhang
Ruiting Wen
Guocai Wu
Guangru Li
Xiaoqing Wu
Yunmiao Guo
Zhigang Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1301236

2,899 views
2 citations

Case Report

Published on 09 Jan 2024

Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report

in Hematologic Malignancies

Silvio Ligia
Emilia Scalzulli
Ida Carmosino
Giovanna Palumbo
Maria Chiara Molinari
Rebecca Poggiali
Alessandro Costa
Maria Laura Bisegna
Maurizio Martelli
Massimo Breccia

Frontiers in Oncology

doi 10.3389/fonc.2023.1338417

2,299 views
1 citation

Review

Published on 08 Jan 2024

Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules

in Hematologic Malignancies

Simona Bernardi
Olga Mulas
Silvia Mutti
Alessandro Costa
Domenico Russo
Giorgio La Nasa

Frontiers in Oncology

doi 10.3389/fonc.2023.1239042

2,645 views
2 citations